Axogen, Inc. (AXGN)
NASDAQ: AXGN · Real-Time Price · USD
41.76
+0.77 (1.87%)
May 18, 2026, 3:27 PM EDT - Market open
Axogen Revenue
Axogen had revenue of $61.46M in the quarter ending March 31, 2026, with 26.56% growth. This brings the company's revenue in the last twelve months to $238.11M, up 22.41% year-over-year. In the year 2025, Axogen had annual revenue of $225.21M with 20.21% growth.
Revenue (ttm)
$238.11M
Revenue Growth
+22.41%
P/S Ratio
9.24
Revenue / Employee
$382,805
Employees
622
Market Cap
2.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 225.21M | 37.87M | 20.21% |
| Dec 31, 2024 | 187.34M | 28.33M | 17.81% |
| Dec 31, 2023 | 159.01M | 20.43M | 14.74% |
| Dec 31, 2022 | 138.58M | 11.23M | 8.81% |
| Dec 31, 2021 | 127.36M | 15.06M | 13.41% |
| Dec 31, 2020 | 112.30M | 5.59M | 5.24% |
| Dec 31, 2019 | 106.71M | 22.78M | 27.13% |
| Dec 31, 2018 | 83.94M | 23.51M | 38.91% |
| Dec 31, 2017 | 60.43M | 19.32M | 46.99% |
| Dec 31, 2016 | 41.11M | 13.78M | 50.41% |
| Dec 31, 2015 | 27.33M | 10.51M | 62.52% |
| Dec 31, 2014 | 16.82M | 5.87M | 53.62% |
| Dec 31, 2013 | 10.95M | 3.26M | 42.33% |
| Dec 31, 2012 | 7.69M | 2.84M | 58.61% |
| Dec 31, 2011 | 4.85M | 1.85M | 61.41% |
| Dec 31, 2010 | 3.00M | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.29B |
| Enovis | 2.28B |
| Integer Holdings | 1.86B |
| Haemonetics | 1.33B |
| Neogen | 870.56M |
| iRhythm Holdings | 787.85M |
| NovoCure | 674.41M |
| TransMedics Group | 635.89M |
AXGN News
- 5 days ago - Axogen Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 18 days ago - Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference - GlobeNewsWire
- 19 days ago - AxoGen price target raised to $48 from $41 at Raymond James - TheFly
- 19 days ago - AxoGen price target raised to $50 from $45 at Canaccord - TheFly
- 19 days ago - AxoGen price target raised to $50 from $39 at H.C. Wainwright - TheFly
- 19 days ago - AxoGen price target raised to $50 from $42 at Citizens - TheFly
- 20 days ago - AxoGen rises 12.8% - TheFly
- 20 days ago - Axogen Earnings Call Transcript: Q1 2026 - Transcripts